Training to Understand and Navigate Emotions and Interactions (TUNE In) for Asperger Syndrome
Phase-Based Progress Estimates
Effectiveness
Safety
Asperger Syndrome+8 More
Training to Understand and Navigate Emotions and Interactions (TUNE In) - BehavioralEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial will test a new three-part treatment strategy to improve social functioning in adults with autism spectrum disorder. The treatment includes components to address social motivation, social anxiety, social cognition, social skills, and generalization of the skills to community settings.
Eligible Conditions
- Asperger Syndrome
- Autism Spectrum Disorders
- Autism Spectrum Disorder
- Pervasive Development Disorder
- Autistic Disorder
- Autism, Early Infantile
Treatment Effectiveness
Effectiveness Progress
Other trials for Asperger Syndrome
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 1 year
1 year
reduction in Social Responsiveness Scale, Second Edition (SRS-2) - Adult (relative/other report)
Trial Safety
Safety Progress
Other trials for Asperger Syndrome
Trial Design
2 Treatment Groups
Nonintervention Group
1 of 2
Intervention Group
1 of 2
Active Control
Experimental Treatment
52 Total Participants · 2 Treatment Groups
Primary Treatment: Training to Understand and Navigate Emotions and Interactions (TUNE In) · No Placebo Group · N/A
Intervention Group
Behavioral
Experimental Group · 1 Intervention: Training to Understand and Navigate Emotions and Interactions (TUNE In) · Intervention Types: BehavioralNonintervention GroupNoIntervention Group · 1 Intervention: Nonintervention Group · Intervention Types:
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
1,816 Previous Clinical Trials
41,115,041 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Who else is applying?
What state do they live in?
| Pennsylvania | 80.0% |
| New York | 20.0% |
How old are they?
| < 18 | 25.0% |
| 18 - 65 | 75.0% |
What site did they apply to?
| Perelman School of Medicine | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 75.0% |
| Did not meet criteria | 25.0% |
How responsive is this trial?
Typically responds via
| 100.0% | |
Most responsive sites:
- Perelman School of Medicine: < 48 hours
Average response time
- < 2 Days
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments